Isaac J. Powell

Urology
1560 E Maple Rd
Troy, MI 48083

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

A Ten Year Experience of Men's Health Events in a Socioeconomically Diverse City in the United States - Lessons Learned.

A Ten Year Experience of Men's Health Events in a Socioeconomically Diverse City in the United States - Lessons Learned.

Journal: Journal of community health
Published: March 09, 2024

Treatment Intensification Patterns and Utilization in Patients with Metastatic Castration-Sensitive Prostate Cancer.

Treatment Intensification Patterns and Utilization in Patients with Metastatic Castration-Sensitive Prostate Cancer.

Journal: Clinical genitourinary cancer
Published: April 22, 2022

DNA Repair Pathways and Their Association With Lethal Prostate Cancer in African American and European American Men.

DNA Repair Pathways and Their Association With Lethal Prostate Cancer in African American and European American Men.

Journal: JNCI cancer spectrum
Published: September 13, 2021

Deconstructing, Addressing, and Eliminating Racial and Ethnic Inequities in Prostate Cancer Care.

Deconstructing, Addressing, and Eliminating Racial and Ethnic Inequities in Prostate Cancer Care.

Journal: European urology
Published: September 11, 2021

Supporting Black voices in urology.

Supporting Black voices in urology.

Journal: Nature reviews. Urology
Published: November 09, 2020

Re: African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from Canary Prostate Cancer Active Surveillance StudyJ. M. Schenk, L. F. Newcomb, Y. Zheng, A. V. Faino, K. Zhu, Y. A. Nyame, J. D. Brooks, P. R. Carroll, M. R. Cooperberg, A. Dash, C. P. Filson, M. E. Gleave, M. Liss, F. M. Martin, T. M. Morgan, P. S. Nelson, I. M. Thompson, A. A. Wagner and D. W. Lin J Urol 2020; 203: 727-733.

Re: African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from Canary Prostate Cancer Active Surveillance StudyJ. M. Schenk, L. F. Newcomb, Y. Zheng, A. V. Faino, K. Zhu, Y. A. Nyame, J. D. Brooks, P. R. Carroll, M. R. Cooperberg, A. Dash, C. P. Filson, M. E. Gleave, M. Liss, F. M. Martin, T. M. Morgan, P. S. Nelson, I. M. Thompson, A. A. Wagner and D. W. Lin J Urol 2020; 203: 727-733.

Journal: The Journal of urology
Published: November 06, 2020

The extrema of circulating miR-17 are identified as biomarkers for aggressive prostate cancer.

The extrema of circulating miR-17 are identified as biomarkers for aggressive prostate cancer.

Journal: American journal of cancer research
Published: May 18, 2018

Risk of Becoming Lost to Follow-up During Active Surveillance for Prostate Cancer.

Risk of Becoming Lost to Follow-up During Active Surveillance for Prostate Cancer.

Journal: European urology
Published: February 10, 2018

Exogenous IL-6 induces mRNA splice variant MBD2_v2 to promote stemness in TP53 wild-type, African American PCa cells.

Exogenous IL-6 induces mRNA splice variant MBD2_v2 to promote stemness in TP53 wild-type, African American PCa cells.

Journal: Molecular oncology
Published: December 19, 2017

Re: Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy: M. S. Leapman, S. J. Freedland, W. J. Aronson, C. J. Kane, M. K. Terris, K. Walker, C. L. Amling, P. R. Carroll and M. R. Cooperberg J Urol 2016;196:1408-1414.

Re: Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy: M. S. Leapman, S. J. Freedland, W. J. Aronson, C. J. Kane, M. K. Terris, K. Walker, C. L. Amling, P. R. Carroll and M. R. Cooperberg J Urol 2016;196:1408-1414.

Journal: The Journal of urology
Published: August 01, 2017

A study of circulating microRNAs identifies a new potential biomarker panel to distinguish aggressive prostate cancer.

A study of circulating microRNAs identifies a new potential biomarker panel to distinguish aggressive prostate cancer.

Journal: Carcinogenesis
Published: June 22, 2017

Legends in Urology.

Legends in Urology.

Journal: The Canadian journal of urology
Published: March 07, 2017
Showing 1-12 of 26

Last Updated: 09/26/2026